Estimates Revisions VYNE Therapeutics Inc.
Equities
VYNE
US92941V3087
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5596 USD | +0.48% |
|
-1.15% | -3.53% |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
| Dec. 17 | VYNE Therapeutics Inc., Yarrow Bioscience, Inc. - M&A Call |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- VYNE Stock
- Consensus VYNE Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
